NATCO PHARMA
Back to Income Statement
|
NATCO PHARMA Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹1,885 Cr | ₹1,388 Cr | ₹715 Cr | ₹170 Cr | ₹441 Cr |
What is the latest Consolidated Net Profit of NATCO PHARMA ?
Year | Consolidated Net Profit |
---|---|
Mar2025 | ₹1,885 Cr |
Mar2024 | ₹1,388 Cr |
Mar2023 | ₹715 Cr |
Mar2022 | ₹170 Cr |
Mar2021 | ₹441 Cr |
How is Consolidated Net Profit of NATCO PHARMA Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2025 | ₹1,885 Cr | 35.81 | |
Mar2024 | ₹1,388 Cr | 94.09 | |
Mar2023 | ₹715 Cr | 320.76 | |
Mar2022 | ₹170 Cr | -61.44 | |
Mar2021 | ₹441 Cr | - |
Compare Consolidated Net Profit of peers of NATCO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NATCO PHARMA | ₹15,279.9 Cr | -1.4% | -8.5% | -44% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹382,622.0 Cr | 2% | -2.3% | -12.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,536.0 Cr | -1.3% | -6.2% | 21.2% | Stock Analytics | |
CIPLA | ₹125,468.0 Cr | -2.2% | 3.6% | -4.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,162.0 Cr | -0% | -0.3% | 5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,874.0 Cr | -0.9% | 4.5% | -8.6% | Stock Analytics |
NATCO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATCO PHARMA | -1.4% |
-8.5% |
-44% |
SENSEX | 1.1% |
-0.4% |
-2.2% |
You may also like the below Video Courses